The Cox regression model and Aalens additive regression model were utilized to compare the risk of OSA between the groups
A telehealth appt with the dr was not required, and my meds shipped the following business day
Overall the results of this study, which followed over 200,000 people with diabetes who were treated with GLP1RAs and compared them to over 1.5 million people on other forms of diabetes treatment, is reassuring regarding the risk/benefit ratio for the long term use of GLP1RAs in people with diabetes
This pattern appears consistently across obesity medications and likely reflects the metabolic differences that accompany established diabetes
Both medications share the same class-level gastrointestinal side effects nausea, vomiting, diarrhea, constipation, and reduced appetite
Regular follow-up appointments are essential to assess the medications effectiveness and manage any side effects